The point of care testing (POCT) market in China was around 1,855 million USD in 2020, reached 2,235 million USD in 2021 (an increase of 20.5% year-on-year), according to StrategyHelix’ analysis.
This 2nd edition of Point of Care Testing (POCT) Market in China includes following information:
Market Overview: Market Size, Grow Rate, CAGR
Application: Blood Glucose Testing, Blood Gas and Electrolyte, Cardiovascular Testing, Infectious Disease Testing, Drug Abuse Testing, Pregnancy Testing, Others
Competitors: Roche Holding AG, Johnson & Johnson, Abbott Laboratories, Sinocare Inc., Guangzhou Wondfo Biotech Co., Ltd., Radiometer A/S, Getein Biotech, Inc., Others
Years Considered: this database covers the period 2014-2021
After you have placed your order and your payment has been authorized, the database download link will be emailed to you instantly. Please note that the database is supplied in an Excel spreadsheet.
StrategyHelix’ data is protected by copyright and cannot be supplied to any third party.
StrategyHelix DataPass produces a series of directories and databases on industries, economies and consumers in Western and Central Europe, North and South America, Asia Pacific, the Middle East and Africa. DataPass aims at helping our clients analyze market context and identify future trends.